Immunovant (IMVT) Receivables (2021 - 2026)
Immunovant (IMVT) recorded Receivables of $697,000 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 64.0% from $1.94 million a year earlier and down 38.5% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Receivables (2021 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant reported Receivables of $1.13 million, down 45.6% from FY2025.
- Annual Receivables has a five-year compound annual growth rate of 13.7% (FY2021 to FY2026).
- Across earlier fiscal years, Receivables came in at $2.08 million in FY2025 (-61.0%), $5.34 million in FY2024 (+662.4%), $700,000 in FY2023 (-94.3%) and $12.23 million in FY2022.
- The fiscal Q1 2027 figure is the lowest quarterly Receivables since fiscal Q4 2021.
- On a year-over-year basis, Receivables has declined for three consecutive quarters, with an average decline of 7.9% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 662.4% in fiscal Q4 2024, against a decline of 94.3% in fiscal Q4 2023 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $1.13 million (Q4 2026), $1.64 million (Q3 2026) and $1.97 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 19.05 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Immunovant | 5.85 Bn | 2.63 Bn | - | 697,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 697,000.00 |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 2.08 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | 5.34 Mn |
| Dec 31, 2023 | 1.03 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 823,000.00 |
| Mar 31, 2023 | 700,000.00 |
| Dec 31, 2022 | 704,000.00 |
| Sep 30, 2022 | 3.78 Mn |
| Jun 30, 2022 | 13.18 Mn |
| Mar 31, 2022 | 12.23 Mn |
| Mar 31, 2021 | 596,000.00 |
API Access
Immunovant Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();